The role of TNF and its receptors in Alzheimer's disease.
about
TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative diseaseRapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease.Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanismEarly correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease miceInflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disordersGlaucomatous neurodegeneration: an eye on tumor necrosis factor-alphaRapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.Cannabinoid receptor activation reduces TNFalpha-induced surface localization of AMPAR-type glutamate receptors and excitotoxicity.Influence of adolescent heavy session drinking on the systemic and brain innate immune system.Peripheral cytokines as a chemical mediator for postconcussion like sickness behaviour in trauma and perioperative patients: literature review.Cerebral FDG-PET scanning abnormalities in optimally treated HIV patients.Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidenceAutocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression.Hippocampal expression of murine TNFα results in attenuation of amyloid deposition in vivo.TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosisTherapeutic Effects of TianDiJingWan on the Aβ 25-35-Induced Alzheimer's Disease Model RatsTumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementiaThe influence of tumour necrosis factor- α (TNF-α) on amyloid-β (Aβ)-degrading enzymes in vitro.Radix Scrophulariae extracts (harpagoside) suppresses hypoxia-induced microglial activation and neurotoxicity.Interleukin-1α, interleukin-1β and tumor necrosis factor-α genetic variants and risk of dementia in the very old: evidence from the "Monzino 80-plus" prospective study.Huperzine A protects neural stem cells against Aβ-induced apoptosis in a neural stem cells and microglia co-culture system.Multiple cytokines are involved in the early events leading to the Alzheimer's disease pathologySubventricular zone neural progenitors reverse TNF-alpha effects in cortical neurons.Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease3,6'-Dithiothalidomide, a new TNF-α synthesis inhibitor, attenuates the effect of Aβ1-42 intracerebroventricular injection on hippocampal neurogenesis and memory deficit.The Role of DNA Methylation and Histone Modifications in Neurodegenerative Diseases: A Systematic ReviewInterleukin 18 gene polymorphisms predict risk and outcome of Alzheimer's disease.Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.Lack of Association between Tumor Necrosis Factor-alpha -308 G/A Polymorphism and Risk of Developing Late-Onset Alzheimer's Disease in an Iranian Population.Expression profiles of cytokines in the brains of Alzheimer's disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathology.Present and prospective clinical therapeutic regimens for Alzheimer's disease.Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship.Effects of TNFalpha-converting enzyme inhibition on amyloid beta production and APP processing in vitro and in vivo.Biomarkers related to aging in human populations.Influence of age on behavioral, immune and endocrine responses to the T-cell superantigen staphylococcal enterotoxin A.Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury.Perispinal etanercept: a new therapeutic paradigm in neurology.Systemic and central immunity in Alzheimer's disease: therapeutic implications.Review: systemic inflammation and Alzheimer's disease.Understanding the neuroinflammatory response following concussion to develop treatment strategies.
P2860
Q21093232-07B44A9D-9A04-4492-BDBF-CEECD63FE507Q21261380-312EBA90-DF17-4768-8C84-D1AA91412291Q24652684-07741570-95E4-4070-B39A-636CC07AD647Q24813024-D3EF7524-857C-4573-8BEA-4E6EFA61143EQ27003260-01C93896-96A3-452D-9189-8DDCD118A947Q27011820-3D496E06-755A-409C-BA38-634D5E5A7F9FQ30481096-48A7329F-F1F0-4507-8AD0-D462D77C39BBQ30573949-43FDFFB2-DE2A-4251-81F4-76B66D7C0C0AQ30758058-C18D2190-2AD5-4AE8-9926-1DCEA78C7E9AQ33607485-68B1F8B7-C112-4A5B-A14B-A716C587CB82Q33728851-0ACC76F8-0617-4B09-AD0E-4E37F4DC5EA6Q33947639-90C237C9-B030-4C90-A331-E9CE5C54E262Q34563098-BBAD7A22-88E8-4F45-8D17-DBC43D9F0A83Q34633199-00A25C39-6B9C-4DB0-9074-6EA472161891Q35005977-D57986DA-1810-48BB-9D27-54DC1CAF40D9Q35169744-7FFEA986-E9B9-4AEF-92CD-2D719DEDFCE4Q35197030-5B7BF253-B9E1-4796-90B0-A3C3E67065CFQ35625868-447C3D2E-03DD-4D12-88AC-51AC450EE8D6Q35775325-A7413876-6B93-4699-BFAA-A84A3545479DQ35853678-212C8184-9F7D-4A7C-98FF-1C20C911B347Q35919007-B7E0E8F9-0F9D-48D6-9A8F-EE61E17E299EQ35954373-C206D23F-42FC-4F80-B761-57D11A2404FCQ36035089-21A93353-E577-43DD-865A-48C591D59CEEQ36118204-650E4B03-CAB0-4A0A-883C-FCECFE6722CCQ36169690-F0D310E3-A061-4AE0-BD7F-03D812ADBB58Q36223734-7E478A49-2EDC-451F-AA02-3975DC70E47EQ36227141-40EA5F54-B97B-4128-BA6D-C4FE34ED57F2Q36330960-B43B6F5C-A65D-463A-AF8F-C01764AA4878Q36571241-1E853E4A-76F6-49BD-8965-75247D34249BQ36611451-1F5E8D31-5260-4AB1-91D1-A5AD074AEC84Q36876447-FC9C149F-2AD4-4683-B9D9-0355B23B08BAQ37069901-E099AD77-4437-48D0-8265-43115323AEC6Q37105896-368C3166-1941-40B6-931B-2AB7A31697C6Q37323794-099B64BA-AEFE-4A1A-9406-D0712FA1C898Q37382711-C457B9C1-B726-4DA7-BE81-AFED44BFC736Q37686762-8CA57EEF-7C6D-45A3-8586-15BF12E12F32Q37762260-FD76A772-736D-452F-A170-13011348DB8DQ37954456-720097BC-7472-4247-A038-BD4DBA505308Q38050498-9656FFF0-A85E-4BA8-9AC8-68E6AFEB0A53Q38068175-926138B9-3166-4054-BF8E-779B299A8A67
P2860
The role of TNF and its receptors in Alzheimer's disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The role of TNF and its receptors in Alzheimer's disease.
@ast
The role of TNF and its receptors in Alzheimer's disease.
@en
The role of TNF and its receptors in Alzheimer's disease.
@nl
type
label
The role of TNF and its receptors in Alzheimer's disease.
@ast
The role of TNF and its receptors in Alzheimer's disease.
@en
The role of TNF and its receptors in Alzheimer's disease.
@nl
prefLabel
The role of TNF and its receptors in Alzheimer's disease.
@ast
The role of TNF and its receptors in Alzheimer's disease.
@en
The role of TNF and its receptors in Alzheimer's disease.
@nl
P2093
P1476
The role of TNF and its receptors in Alzheimer's disease.
@en
P2093
P304
P356
10.1016/S0197-4580(01)00291-3
P577
2001-11-01T00:00:00Z